Home › Funds › BVF INC/IL › STRO
BVF INC/IL position in STRO
SUTRO BIOPHARMA INC · Health Care
BVF INC/IL reported holding 1,251,788 shares of STRO (SUTRO BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$41.6M, representing 1.06% of its reported portfolio and ranking #23 among its reported holdings. BVF INC/IL has disclosed STRO holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's STRO position evolved
BVF INC/IL first disclosed a stake in STRO in Q3 2023 at 3,347,946 shares (US$11.6M). The position peaked in Q2 2026 at 1,251,788 shares, worth US$41.6M. Across 4 filings, BVF INC/IL held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,251,788 shares valued at US$41.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.35M | $11.62M | New |
| Q4 2023 | 3.35M | $14.36M | Hold |
| Q1 2026 | 1.25M | $31.18M | New |
| Q2 2026 | 1.25M | $41.56M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STRO and 13F data
STRO (SUTRO BIOPHARMA INC) is a Health Care company. 45 other funds we track also report a position in STRO — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$43.3M), Affinity Asset Advisors, LLC (US$38.9M), Samsara BioCapital, LLC (US$35.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STRO
- PERCEPTIVE ADVISORS LLC 1.30M sh · $43.32M · Q2 2026
- Affinity Asset Advisors, LLC 1.17M sh · $38.93M · Q2 2026
- Samsara BioCapital, LLC 1.06M sh · $35.29M · Q2 2026
- Kynam Capital Management, LP 872.56K sh · $28.97M · Q2 2026
- Velan Capital Investment Management LP 512.16K sh · $17.00M · Q2 2026
- ADAR1 Capital Management, LLC 404.01K sh · $13.41M · Q2 2026
- Merck & Co., Inc. 272.35K sh · $9.04M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 270.25K sh · $8.97M · Q2 2026
- KVP Capital Advisors, LP 226.57K sh · $7.52M · Q2 2026
- Seven Fleet Capital Management LP 159.12K sh · $3.79M · Q2 2026
FAQ
How long has BVF INC/IL held STRO?
BVF INC/IL has disclosed STRO holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in STRO?
As of Q2 2026, BVF INC/IL holds 1.25M shares of STRO (SUTRO BIOPHARMA INC), valued at $41.56M, representing 1.06% of its reported portfolio and ranking #23.
Has BVF INC/IL been buying or selling STRO?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in STRO. The position peaked in Q2 2026 at 1.25M shares.
Which other funds hold STRO?
Other major institutional holders of STRO include PERCEPTIVE ADVISORS LLC, Affinity Asset Advisors, LLC, Samsara BioCapital, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.